Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment

Overall survival (OS) in patients with advanced hepatocellular carcinoma (HCC) has improved in the era of multi-line sequential therapy. The application of antiviral therapy and its impact on survival for patients with HBV-related HCC needs to be reassessed. The aim of this study was to evaluate the...

Descripció completa

Dades bibliogràfiques

Autors principals:	I-Cheng Lee, Pei-Chang Lee, Yee Chao, Chen-Ta Chi, Chi-Jung Wu, Yi-Ping Hung, Chien-Wei Su, Ming-Chih Hou, Yi-Hsiang Huang
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2022-10-01
Col·lecció:	Viruses
Matèries:	hepatitis B virus hepatocellular carcinoma tyrosine kinase inhibitor antiviral therapy sorafenib lenvatinib
Accés en línia:	https://www.mdpi.com/1999-4915/14/11/2355
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!